162 filings
Page 4 of 9
8-K
d1o3r6jjc
5 Aug 21
Moderna Reports Second Quarter Fiscal Year 2021 Financial Results and Provides Business Updates
6:42am
8-K
wanpcg
6 May 21
Moderna Reports First Quarter Fiscal Year 2021 Financial Results and Provides Business Updates
7:29am
8-K
3sp rbn3e840ffjoryhv
29 Apr 21
Submission of Matters to a Vote of Security Holders
4:17pm
8-K
82qrqrp4kxrlu
28 Apr 21
Other Events
7:33am
SEC STAFF
6521j2rzq21u
16 Apr 21
SEC staff action: Order
12:00am
8-K
klkne accqil7lm683a0
13 Apr 21
Moderna Provides Clinical and Supply Updates on COVID-19 Vaccine Program Ahead of 2nd Annual Vaccines Day
5:28pm
8-K
tot5z31
13 Apr 21
Regulation FD Disclosure
10:41am
SEC STAFF
eu8tn4kcki5xleam9h8c
19 Mar 21
SEC staff action: Order
12:00am
DEFA14A
3b7ssr9illwa qizx
10 Mar 21
Additional proxy soliciting materials
4:41pm
8-K
5qu0b5t
10 Mar 21
Departure of Directors or Certain Officers
4:31pm
8-K
sm4ohgz1
25 Feb 21
Moderna Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides Business Updates
7:07am
8-K
au1t djxxximyo6of4f0
4 Jan 21
Results of Operations and Financial Condition
8:06am
8-K
wjyppz6r3b8i
23 Dec 20
Regulation FD Disclosure
7:48am
8-K
fi8b hmi4
21 Dec 20
Regulation FD Disclosure
7:03am
8-K
a81 3yvnrqki6tl
11 Dec 20
Regulation FD Disclosure
4:40pm
8-K
299xla
30 Nov 20
Regulation FD Disclosure
7:04am
8-K
c1g2xz yd
16 Nov 20
Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study
7:01am